Alpha is often seen as a sign of a fund manager’s ability to beat the benchmark. A Value Research screening…
With mid-cap companies attracting investor attention amid India’s structural growth themes, here are leading mid-cap mutual funds to watch.
A five-year delay in starting a SIP may seem insignificant in your 20s, but it can have a massive impact…
Many young investors end up holding six or more mutual funds in the name of diversification. But do you really…
Over the past 10 years, a very few 5-star rated mutual funds rewarded that patience shown by investors by delivering…
Among the best-performing tax-saving mutual funds over the past five years, Motilal Oswal ELSS Tax Saver Fund has delivered the…
India’s SIP stoppage ratio crossed 100% in March and April 2026, meaning more SIP accounts were closed or matured than…
Inflows and folio additions plunge as investors move to diversified categories
Over the last 3 years, SBI PSU Fund Direct Plan has delivered a 31.95% CAGR, making it one of the…
Can a Rs 10,000 monthly SIP really turn into nearly Rs 1.2 crore? Surprisingly, only two mutual funds in India’s…
Flexi Cap Funds are often called ‘all-weather’ mutual funds to their flexible mandates.
Why some SIP investors fail to build wealth: 6 asset allocation mistakes to avoid
Looking for low-cost mutual funds? These 5-star equity funds delivered up to 15.46% returns even as Sensex and Nifty struggled.
Many accomplished individuals dedicate immense energy to creating wealth, yet fail to ask critical questions when protecting it. PPFAS Wealth…
Contra mutual funds, which focus on undervalued and out-of-favour stocks, are gaining attention as select schemes continue to outperform benchmark…
Here are best mutual funds from a combined quantitative score gauged on metrics like standard deviation, sharpe, sortino, and up/down…
While many equity mutual fund categories struggled amid market volatility over the past year, multi asset allocation funds emerged as…
Investors are increasingly tracking pharma mutual funds for sector-focused opportunities. We reviewed five leading pharma mutual funds based on returns,…